These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 5075944

  • 1. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.
    Slatopolsky E, Rutherford WE, Hoffsten PE, Elkan IO, Butcher HR, Bricker NS.
    Kidney Int; 1972; 1(1):38-46. PubMed ID: 5075944
    [No Abstract] [Full Text] [Related]

  • 2. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH, Ritz E.
    MMW Munch Med Wochenschr; 1976 Jan 30; 118(5):129-30. PubMed ID: 814442
    [No Abstract] [Full Text] [Related]

  • 3. Parathyroid acidosis in uraemia.
    Muldowney FP, Donohoe JF, Carroll DV, Powell D, Freaney R.
    Q J Med; 1972 Jul 30; 41(163):321-42. PubMed ID: 5072056
    [No Abstract] [Full Text] [Related]

  • 4. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D, Galmozzi C, Pizzocaro G.
    Minerva Med; 1985 Mar 10; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract] [Full Text] [Related]

  • 5. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E, Mioni G, Maschio G, D'Angelo A, Ossi E.
    Nephron; 1975 Mar 10; 14(2):163-80. PubMed ID: 1093055
    [Abstract] [Full Text] [Related]

  • 6. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
    Slatopolsky E, Caglar S, Gradowska L, Canterbury J, Reiss E, Bricker NS.
    Kidney Int; 1972 Sep 10; 2(3):147-51. PubMed ID: 4669450
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy].
    Sforzini S, Viganò MR, Rosa M, Redaelli B.
    Minerva Med; 1985 Mar 10; 76(9-10):393-6. PubMed ID: 3982696
    [No Abstract] [Full Text] [Related]

  • 8. Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.
    Black WC, Slatopolsky E, Elkan I, Hoffsten P.
    Lab Invest; 1970 Nov 10; 23(5):497-509. PubMed ID: 5483883
    [No Abstract] [Full Text] [Related]

  • 9. Medical management of secondary hyperparathyroidism in uremia.
    Drüeke TB.
    Am J Med Sci; 1999 Jun 10; 317(6):383-9. PubMed ID: 10372838
    [Abstract] [Full Text] [Related]

  • 10. Medical treatment in primary and secondary hyperparathyroidism.
    Coburn JW, Brickman AS, Massry SG.
    Semin Drug Treat; 1972 Jun 10; 2(1):117-35. PubMed ID: 4261783
    [No Abstract] [Full Text] [Related]

  • 11. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S.
    Acta Med Scand Suppl; 1980 Jun 10; 638():3-120. PubMed ID: 6929650
    [No Abstract] [Full Text] [Related]

  • 12. The effect of subtotal parathyroidectomy and renal transplantation on mineral balance and secondary hyperparathyroidism in chronic renal failure.
    Johnson JW, Wachman A, Katz AI, Bernstein DS, Hampers CL, Hattner RS, Wilson RE, Merrill JP.
    Metabolism; 1971 May 10; 20(5):487-500. PubMed ID: 4931815
    [No Abstract] [Full Text] [Related]

  • 13. Indications for parathyroidectomy in advanced renal disease.
    Buck BA, Robertson RD.
    Surg Gynecol Obstet; 1971 Aug 10; 133(2):218-24. PubMed ID: 4935588
    [No Abstract] [Full Text] [Related]

  • 14. Metabolic problems in renal transplant patients. Persistent hyperparathyroidism and hypophosphatemia: effects of intravenous calcium infusion.
    Pabico RC, McKenna BA.
    Transplant Proc; 1988 Feb 10; 20(1 Suppl 1):438-42. PubMed ID: 3279634
    [No Abstract] [Full Text] [Related]

  • 15. Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis.
    Massry SG, Coburn JW, Peacock M, Kleeman CR.
    Trans Am Soc Artif Intern Organs; 1972 Feb 10; 18(0):416-22. PubMed ID: 4679896
    [No Abstract] [Full Text] [Related]

  • 16. Vitamin D and its analogs in chronic renal failure.
    Slatopolsky E, Brown AJ.
    Osteoporos Int; 1997 Feb 10; 7 Suppl 3():S202-8. PubMed ID: 9536333
    [No Abstract] [Full Text] [Related]

  • 17. Hyperparathyroidism and renal failure.
    Arnaud CD.
    Kidney Int; 1973 Aug 10; 4(2):89-95. PubMed ID: 4598144
    [No Abstract] [Full Text] [Related]

  • 18. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A, Bordier P, Weil B, Safar M, Idatte JM.
    Presse Med (1893); 1971 Oct 27; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 27; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Parathyroidectomy in the treatment of secondary renal hyperparathyroidism.
    Ogg CS.
    Kidney Int; 1973 Aug 27; 4(2):168-73. PubMed ID: 4583085
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.